Cedars Sinai

Margaret Liang, MD, MSPHM, has been appointed director of the gynecologic oncology fellowship program for Cedars-Sinai Cancer Center.

Heart transplant is the most effective treatment for end-stage HF but it is also the scarcest of HF therapies — particularly for patients from underrepresented racial and ethnic groups.

PHILADELPHIA — In this Healio video exclusive, Healio | Cardiology Today Editorial Board Member Susan Cheng, MD, MPH, MMSc, discusses the excess risk for heart attack in patients with COVID-19.

BALTIMORE — Black and Hispanic women may be less likely to receive a recommendation to restrict activity during pregnancy compared with white women, according to research presented at the ACOG Annual Clinical & Scientific Meeting.

Patients who underwent a second transcatheter aortic valve replacement were no more likely to experience adverse in-hospital, 30-day and 1-year outcomes than those after a first TAVR, according to an analysis of real-world registry data.

SAN DIEGO — At the ACP Internal Medicine Meeting, Kimberly D. Gregory, MD, MPH, chair of the advisory panel of the Women’s Preventive Services Initiative, reviewed recent guidelines from the organization that physicians should be aware of.

The addition of enzalutamide to androgen deprivation therapy extended metastasis-free survival among men with nonmetastatic, hormone-sensitive prostate cancer with high-risk biochemical recurrence, according to study results.

In women with ischemic heart disease, poor fitness and metabolic syndrome with or without diabetes independently drive risks for obstructive coronary artery disease, long-term adverse events and all-cause mortality, researchers reported.

Teprotumumab is associated with a greater reduction in proptosis than placebo at 24 weeks among adults with chronic thyroid eye disease and a low clinical activity score, according to topline results.

Healthy adults with spherical hearts, identified through a deep learning analysis of cardiac MRI images, were 31% more likely to develop atrial fibrillation and 24% more likely to develop cardiomyopathy, researchers reported.